John T. Carpenter, MD, was appointed Professor Emeritus of Hematology and Oncology. Dr. Carpenter joined UAB in 1973 as Assistant Professor in Hematology and Oncology. During his tenure he also held appointments in Pathology, Medicine, and Surgery; and he directed UAB Hospital’s Bone Marrow Laboratory from 1974 to 1994. Dr. Carpenter was also active on local and national professional committees and was the recipient of various honors, including Outstanding Teacher in the UAB Division of Hematology and Oncology
Kendra Sheppard, MD (Gerontology, Geriatrics, and Palliative Care) has been selected for the School of Medicine Faculty Scholars Program in Health Disparities and Culturally Responsive Care. The program is designed to generate a cadre of teaching faculty who will champion the integration of health disparity and cultural competency training into medical education at UAB.
Kendra Sheppard, MD (Gerontology, Geriatrics, and Palliative Care) has been selected for the School of Medicine Faculty Scholars Program in Health Disparities and Culturally Responsive Care. The program is designed to generate a cadre of teaching faculty who will champion the integration of health disparity and cultural competency training into medical education at UAB.
The UAB Comprehensive Cancer Center is enrolling lung cancer patients into two leading national clinical trials: LUNG-MAP and Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial. These trials will perform screening on the tumors of all participants to determine the genetic alterations that drive their specific lung cancer and that could potentially be inhibited by a molecularly-targeted therapeutic. Francisco Robert, MD (Hematology and Oncology) is encouraging patients with early-stage lung cancer to enroll in these trials to receive early treatment with drugs that target their specific genetic mutations, with the hope of halting or reversing the progress of the disease and extending the patients’ lives.
Gareth R. Dutton, PhD (Preventive Medicine) is Principal Investigator for an R01 grant that was recently awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to conduct a randomized controlled trial comparing lifestyle interventions with differing levels and schedules of energy reduction for weight loss and weight loss maintenance. The project entitled “Fixed Versus Variable Energy Reduction During Behavioral Obesity Treatment,” is gearing up to begin participant recruitment later this year or early 2016.
Steve Duncan, MD (Pulmonary, Allergy and Critical Care Medicine) recently found that patients with acute exacerbations of idiopathic pulmonary fibrosis responded well to therapies similar to those used to treat autoimmune diseases. His findings “Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis” were just published in PLOS ONE. Read the full story here.
Edward W. Hook, MD (Director, Infectious Diseases) co-authored a viewpoint article with former Surgeon General David Satcher, MD, PhD, and current ASHA Board member Eli Coleman, PhD, that was recently published in the Journal of the American Medical Association. In “Sexual Health in America: Improving Patient Care and Public Health,” they assert that physicians can move toward solutions by embracing a comprehensive sexual health framework that looks towards the promotion of health and wellness rather than a narrow fixation on diseases.
The UAB Benevolent Fund is building its second house with Habitat for Humanity this fall. The School of Medicine is scheduled to volunteer on the first weekend of the build—Friday, September 18, and Saturday, September 19. Sign up here for a four-hour shift by Wednesday, August 12.
Coming Next Week: Richard Green, MD, Professor of Gastroenterology and Hepatology at Northwestern University will present "Non-alcoholic Fatty Liver Disease. Treating the Epidemic."
View this week's slides here.
Do you have Good News to share? If so, please email the Department of Medicine's Director of Communications, Carolyn Walsh.